Bill Sponsors: NY A09535 | 2023-2024 | General Assembly

Bill Title: Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-03-20 - referred to health [A09535 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Assemblymember Phillip Steck [D]PrimarySponsored BillsHD-110FollowTheMoneyBallotpediaVoteSmart

Social Comments on NY A09535

feedback